Thursday, December 11th, 2025: Day ThreeThursday, 11 December 2025 - ET (Eastern Time, GMT-05:00)

Gain actionable insights on WAC optimization strategies, pricing governance models and access-driven pricing approaches that drive both commercial success and patient affordability

Manage the gross-to-net bubble across diverse product portfolios including branded pharmaceuticals, generics and biosimilars to maximize financial performance

Understand financial reporting risks associated with complex distribution channel dynamics

Gain insight on the current status of Most Favored Nation pricing implementation for January 1st and what stakeholders can expect from upcoming regulatory changes

Hear more about latest NCPDP standards developments and CMS pledges for advancing interoperability within healthcare systems to improve data exchange and care coordination

Understand stakeholder action plans for digital therapeutics integration and opportunities for expanding clinical services in pharmacy settings to enhance patient care delivery

Explore how to maximize the potential of existing commercial structures and teams to secure assets with commercial potential

Understand how to position your company to navigate future market volatility and events, ensuring long-term growth and stability

Discover the benefits of forming strategic partnerships, joint ventures and alliances to drive growth and share risks in the pharmaceutical market

Examine the rapidly evolving digital therapeutics market, including growth projections, regulatory developments and emerging therapeutic areas showing highest adoption potential

Discover optimal distribution models for digital health products, from direct-to-provider pathways to pharmaceutical partnerships, payer integration and consumer-directed approaches

Learn effective collaboration frameworks between digital therapeutic companies and channel partners, including value creation strategies, revenue models and integration best practices